Viatris Inc

Healthcare · Drug Manufacturers - Specialty & Generic

17.00$ -1.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Viatris Inc (VTRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 14,300 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VTRS
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	440	529	721	790	847	1,104	1,269	1,375	1,253	1,257	1,612	2,905	5,138	5,093	5,451	6,130	6,796	6,909	7,720	9,429	11,077	11,908	11,434	11,501	11,946	17,886	16,263	15,427	14,739	14,300
Cost of Revenue	242	267	310	326	422	480	598	612	630	630	768	1,739	3,067	3,018	3,233	3,566	3,888	3,869	4,192	5,213	6,380	7,125	7,432	7,603	8,149	12,311	9,766	8,988	9,116	9,286
Gross Profit	198	262	411	464	425	624	671	762	624	628	844	1,166	2,070	2,074	2,217	2,563	2,908	3,040	3,528	4,216	4,697	4,783	4,002	3,898	3,797	5,576	6,497	6,439	5,624	5,014
Research & Development	43	46	62	49	64	59	87	101	88	102	104	195	317	275	282	295	401	508	582	672	827	783	705	640	513	681	662	805	809	966
Selling, General & Administrative	80	97	125	156	151	170	173	202	259	226	216	–	1,053	1,050	1,087	1,215	1,401	1,412	1,626	2,181	2,496	2,576	2,441	2,564	3,344	4,529	4,179	4,310	4,426	3,794
Total Operating Expenses	140	165	214	241	363	229	257	268	321	340	269	794	1,772	1,551	1,496	1,558	1,799	1,905	2,175	2,755	3,998	3,346	3,096	3,182	4,008	5,610	4,882	5,672	5,614	7,677
Operating Income	58	97	198	223	20	395	414	495	302	287	428	372	298	523	722	1,005	1,109	1,136	1,353	1,461	699	1,437	906	716	-211	-34	1,615	766	10	-2,663
Interest Expense	58	102	10	40	111	31	32	77	46	31	196	239	381	267	278	333	319	313	333	336	455	535	542	517	498	636	592	573	550	471
Pre-Tax Income	87	148	192	243	58	408	427	513	312	275	426	-1,441	-72	227	356	655	804	747	975	915	122	903	298	154	-721	-664	2,813	203	-623	-3,665
Income Tax Expense	24	48	77	88	21	148	154	178	109	90	208	80	129	-21	10	116	161	121	41	68	-358	207	-54	138	-51	605	735	148	11	-150
Net Income	63	101	115	154	37	260	272	335	204	185	217	-1,517	-196	233	345	537	641	624	929	848	480	696	353	17	-670	-1,269	2,079	55	-634	-3,515
EBITDA	46	68	230	239	211	423	435	539	347	334	683	-992	735	947	1,110	1,501	1,660	1,577	1,874	2,287	2,100	3,243	2,951	2,691	1,993	4,478	6,433	3,517	2,820	-395

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings